HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life

NCT05373264 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

ADPKD

Interventions

DRUG: Hydrochlorothiazide 25 mg
DRUG: Placebo

Sponsor

University Medical Center Groningen